<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01868256</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-PAP-2011-07</org_study_id>
    <nct_id>NCT01868256</nct_id>
  </id_info>
  <brief_title>Safety of Early Discharge Following Low Risk Myocardial Infarction</brief_title>
  <acronym>EDAMI</acronym>
  <official_title>Safety of a Early Discharge Strategy in Patients With Low-risk ST-segment Elevation Myocardial Infarction Treated With Primary Coronary Intervention: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Objectives: The primary objective of this study is to evaluate the safety of an early
           discharge strategy in patients with low risk ST-elevation myocardial infarction (STEMI),
           treated with primary percutaneous coronary intervention (PPCI), compared to a
           conventional strategy.

        -  Methodology: Unicentric, randomized, controlled, non-inferiority and open label clinical
           trial. The investigators will compare an early discharge strategy (≤72 hours) with a
           conventional strategy (discharge according to treating physician's criterion). Inclusion
           criteria will be: low risk (Zwolle risk score ≤3) STEMI treated with PPCI within 24
           hours from symptoms onset. Exclusion criteria will be: arrhythmias (ventricular
           tachycardia or fibrillation, asystole, pulseless electrical activity, advanced
           atrio-ventricular block), mechanical complications (cardiac tamponade, free-wall or
           septal rupture, acute mitral regurgitation, pericarditis), severe or moderate bleeding
           (according to the GUSTO criteria), complications related to vascular access of the
           procedure, acute kidney failure, infection, heart failure. Sample size will be 1558
           subjects (n=779 per group). The investigators will study demographic, clinical,
           biochemical, echocardiographic and angiographic variables. The primary endpoint will be
           a composite of death, reinfarction, new angina, heart failure, ventricular arrhythmias,
           stroke and severe bleeding. The secondary endpoint will include each of the items of the
           primary endpoint and quality of life and functional capacity questionnaire SF-36.
           Finally, the investigators will analyze the degree of compliance with the European
           Society of Cardiology guidelines on STEMI and the rate of hospitalization-related
           complications. Follow up will be at 30 days.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality, new acute myocardial infarction, new unstable angina, heart failure, ventricular arrhythmias, stroke and severe bleeding.</measure>
    <time_frame>1 month</time_frame>
    <description>Composite primary end-point</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unstable angina</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular arrhythmias</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe bleeding</measure>
    <time_frame>1 month</time_frame>
    <description>According to the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) classification</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Difference in quality of life and functional capacity questionnaire SF-36.</measure>
    <time_frame>1 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Compliance of treatment</measure>
    <time_frame>1 month</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1558</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Early discharge (&lt; 72 h)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized the early discharge group will be discharged from the hospital in &lt; 72 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional discharge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the conventional discharge group will be discharged according to the local hospital protocol and/or treating physician criterion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>early discharge (&lt;72 h)</intervention_name>
    <arm_group_label>Early discharge (&lt; 72 h)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional discharge</intervention_name>
    <arm_group_label>Conventional discharge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  low risk (Zwolle risk score ≤3) STEMI treated with PPCI within 24 hours from symptoms
             onset

          -  Informed consent

        Exclusion Criteria:

          -  arrhythmias (ventricular tachycardia or fibrillation, asystole, pulseless electrical
             activity, advanced atrio-ventricular block)

          -  mechanical complications (cardiac tamponade, free-wall or septal rupture, acute mitral
             regurgitation, pericarditis)

          -  severe or moderate bleeding (according to the GUSTO criteria)

          -  complications related to vascular access of the procedure

          -  acute kidney failure

          -  infection

          -  heart failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandro Sionis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Sionis, MD</last_name>
      <phone>+ 34 935565945</phone>
      <email>asionis@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Alessandro Sionis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Newby LK, Eisenstein EL, Califf RM, Thompson TD, Nelson CL, Peterson ED, Armstrong PW, Van de Werf F, White HD, Topol EJ, Mark DB. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000 Mar 16;342(11):749-55.</citation>
    <PMID>10717009</PMID>
  </reference>
  <reference>
    <citation>De Luca G, Suryapranata H, van 't Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, Gosselink AT, Ottervanger JP, Zijlstra F. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004 Jun 8;109(22):2737-43. Epub 2004 May 24.</citation>
    <PMID>15159293</PMID>
  </reference>
  <reference>
    <citation>Grines CL, Marsalese DL, Brodie B, Griffin J, Donohue B, Costantini CR, Balestrini C, Stone G, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Sachs D, Grines LL, O'Neill W. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998 Apr;31(5):967-72.</citation>
    <PMID>9561995</PMID>
  </reference>
  <reference>
    <citation>Kotowycz MA, Cosman TL, Tartaglia C, Afzal R, Syal RP, Natarajan MK. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). Am Heart J. 2010 Jan;159(1):117.e1-6. doi: 10.1016/j.ahj.2009.10.024.</citation>
    <PMID>20102876</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2013</study_first_posted>
  <last_update_submitted>May 30, 2013</last_update_submitted>
  <last_update_submitted_qc>May 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>myocardial infarction</keyword>
  <keyword>primary percutaneous intervention</keyword>
  <keyword>prognosis</keyword>
  <keyword>early discharge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

